Fig. 2
Length of BZD use and cross-country differencesa. aBG – Bulgaria, CZ – Czech Republic, EE – Estonia, ES – Spain, HR – Croatia, RS – Serbia, TR – Turkey; N – Number of BZDs used in the country; Percentages were calculated using a denominator including missing values. When missing values were excluded from denominator (N = 365) the corresponding results were: in total sample of BZD users 0.8% of patients used BZDs for period of less than 1 month, 3.8% for 1 – 6 months, 12.9% for 6 months – 1 year, 40.5% for 1 – 5 years, and 41.9% for more than 5 years